Induction of Tumor Cell Dormancy by Ribosomal Intergenic Spacer Noncoding RNA

核糖体基因间间隔区非编码 RNA 诱导肿瘤细胞休眠

基本信息

  • 批准号:
    9002643
  • 负责人:
  • 金额:
    $ 35.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-12-01 至 2020-11-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The ability of cancer cells to adapt to a wide variety of stress conditions plays a critical role in various physiological facets of tumorigenesis. We recently reported the discovery of a class of stress-induced long noncoding RNAs derived from stimuli-specific loci of the ribosomal intergenic spacer (Mol. Cell (2012) 45:147), a puzzling region of the human genome historically assumed to be transcriptionally inactive. Induction of rDNA intergenic spacer RNA (IGSRNA) converts the nucleolus from a factory of ribosomes to the Nucleolar Detention Center: a molecular prison that immobilizes specific proteins in response to extracellular stressors (Nature Cell Biol. (2004) 6:642; J.Cell. Biol. (2005) 170:733; Mol. Biol. Cell. (2013) 24: 2943). The Nucleolar Detention Center is observed in cells that populate the core of human tumors and is induced by various cancer-related stressors, including extracellular acidosis and the anti-mitotic therapeutic doxorubicin. We will show preliminary data that the Nucleolar Detention Center comprises of a biochemically heterogeneous population of proteins including elements of the DNA synthesis machinery. Cancer cells activate IGSRNA- mediated nucleolar immobilization of proteins to reduce metabolism and withdraw from the cell cycle in an adaptive response to severe environmental insults. This raises the fascinating possibility that the IGSRNA are involved in the attainment of tumor cell dormancy, a critical phenotype in a cancer cell's ability to sustain viability in the hash conditions of the tumor microenvironment and resist anti-cancer therapy. Based on these aforementioned rationales, we propose the following hypothesis: Stimuli-specific formation of the Nucleolar Detention Center by IGSRNA induces tumor cell dormancy. In the Specific Aims, we will: 1- Survey the ribosomal intergenic spacer for IGSRNA induced by cancer-related stressors; 2- Examine the specific Nucleolar Detention Center proteomes as a function of various stress conditions; 3- Demonstrate a role for the IGSRNA-mediated Nucleolar Detention Center in the dormant tumor cell phenotype. The discovery of the IGSRNA-regulated Nucleolar Detention Center constitutes a unique and remarkable window of opportunity to investigate a largely unexplored post-translational mechanism potentially involved in tumor cell dormancy. These studies will yield significant conceptual advances in our understanding of critical adaptive/resistance processes exploited by cancer cells to sustain viability in the tumor microenvironment and resistance to anti- cancer drugs.
 描述(由申请人提供):癌细胞适应各种应激条件的能力在肿瘤发生的各种生理学方面起着关键作用。我们最近报道了一类应激诱导的长非编码RNA的发现,这些长非编码RNA来源于核糖体基因间间隔区(Mol. Cell(2012)45:147),这是人类基因组中一个令人困惑的区域,历史上被认为是转录失活的。rDNA基因间间隔区RNA(IGSRNA)的诱导将核仁从核糖体工厂转化为核仁滞留中心(Nucleolar Detention Center):响应于细胞外应激物而固定特定蛋白质的分子监狱(Nature Cell Biol.(2004)6:642; J.Cell.(2005)170:733; Mol.生物细胞(2013)24:2943)。核仁滞留中心在人类肿瘤核心的细胞中观察到,并由各种癌症相关的应激源诱导,包括细胞外酸中毒和抗有丝分裂治疗药物阿霉素。我们将展示的初步数据表明,核仁滞留中心包括一个生物化学异质性人口的蛋白质,包括元素的DNA合成机制。癌细胞激活IGSRNA介导的蛋白质的核仁固定以减少代谢并在对严重环境损伤的适应性反应中退出细胞周期。这提出了IGSRNA参与实现肿瘤细胞休眠的迷人可能性,这是癌细胞在肿瘤微环境的散列条件下维持生存能力和抵抗抗癌治疗的关键表型。基于上述理论,我们提出了以下假设:IGSRNA刺激特异性形成的核仁滞留中心诱导肿瘤细胞休眠。在具体目标中,我们将:1-调查癌症相关应激源诱导的IGSRNA的核糖体基因间间隔区; 2-检查特定的核仁滞留中心蛋白质组与各种应激条件的关系; 3-证明IGSRNA介导的核仁滞留中心在休眠肿瘤细胞表型中的作用。IGSRNA调节的核仁滞留中心的发现构成了一个独特而显着的机会窗口,以调查可能涉及肿瘤细胞休眠的大量未探索的翻译后机制。这些研究将在我们对癌细胞利用关键适应/抗性过程的理解中产生重大的概念性进展,以维持肿瘤微环境中的活力和对抗癌药物的抗性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen Lee其他文献

Stephen Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen Lee', 18)}}的其他基金

The Nucleolar Detention Center: A Hub of Long Noncoding RNA that Imprison Proteins during Stress
核仁拘留中心:在压力下囚禁蛋白质的长非编码 RNA 中心
  • 批准号:
    10622035
  • 财政年份:
    2023
  • 资助金额:
    $ 35.11万
  • 项目类别:
Amyloid-bodies and the Evolution of Malignancies
淀粉样蛋白体和恶性肿瘤的进化
  • 批准号:
    10736039
  • 财政年份:
    2023
  • 资助金额:
    $ 35.11万
  • 项目类别:
The Nucleolar Detention Center: a Hub of Long Noncoding RNAs that Imprison Proteins During Stress
核仁拘留中心:在压力下囚禁蛋白质的长非编码 RNA 中心
  • 批准号:
    9903375
  • 财政年份:
    2015
  • 资助金额:
    $ 35.11万
  • 项目类别:
The Nucleolar Detention Center: a Hub of Long Noncoding RNAs that Imprison Protei
核仁拘留中心:囚禁蛋白质的长非编码 RNA 中心
  • 批准号:
    9261552
  • 财政年份:
    2015
  • 资助金额:
    $ 35.11万
  • 项目类别:
The Nucleolar Detention Center: a Hub of Long Noncoding RNAs that Imprison Protei
核仁拘留中心:囚禁蛋白质的长非编码 RNA 中心
  • 批准号:
    8936277
  • 财政年份:
    2015
  • 资助金额:
    $ 35.11万
  • 项目类别:
The Nucleolar Detention Center: a Hub of Long Noncoding RNAs that Imprison Proteins During Stress
核仁拘留中心:在压力下囚禁蛋白质的长非编码 RNA 中心
  • 批准号:
    10355499
  • 财政年份:
    2015
  • 资助金额:
    $ 35.11万
  • 项目类别:
Induction of Tumor Cell Dormancy by Ribosomal Intergenic Spacer Noncoding RNA
核糖体基因间间隔区非编码 RNA 诱导肿瘤细胞休眠
  • 批准号:
    9186532
  • 财政年份:
    2015
  • 资助金额:
    $ 35.11万
  • 项目类别:
The Nucleolar Detention Center: a Hub of Long Noncoding RNAs that Imprison Proteins During Stress
核仁拘留中心:在压力下囚禁蛋白质的长非编码 RNA 中心
  • 批准号:
    10624488
  • 财政年份:
    2015
  • 资助金额:
    $ 35.11万
  • 项目类别:

相似海外基金

Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
  • 批准号:
    9975367
  • 财政年份:
    2020
  • 资助金额:
    $ 35.11万
  • 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
  • 批准号:
    16K11932
  • 财政年份:
    2016
  • 资助金额:
    $ 35.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
  • 批准号:
    19591274
  • 财政年份:
    2007
  • 资助金额:
    $ 35.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
  • 批准号:
    6346309
  • 财政年份:
    2000
  • 资助金额:
    $ 35.11万
  • 项目类别:
TRAINING IN PHARMACOLOGY OF ANTINEOPLASTIC AGENTS
抗肿瘤药物药理学培训
  • 批准号:
    2720213
  • 财政年份:
    1999
  • 资助金额:
    $ 35.11万
  • 项目类别:
TRAINING IN PHARMACOLOGY OF ANTINEOPLASTIC AGENTS
抗肿瘤药物药理学培训
  • 批准号:
    6513197
  • 财政年份:
    1999
  • 资助金额:
    $ 35.11万
  • 项目类别:
Training in Pharmacology of Antineoplastic Agents
抗肿瘤药物药理学培训
  • 批准号:
    7101017
  • 财政年份:
    1999
  • 资助金额:
    $ 35.11万
  • 项目类别:
Training in Pharmacology of Antineoplastic Agents
抗肿瘤药物药理学培训
  • 批准号:
    6894842
  • 财政年份:
    1999
  • 资助金额:
    $ 35.11万
  • 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
  • 批准号:
    2885074
  • 财政年份:
    1999
  • 资助金额:
    $ 35.11万
  • 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
  • 批准号:
    6174221
  • 财政年份:
    1999
  • 资助金额:
    $ 35.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了